Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dongsheng Tu

Showing results (11-20 of 200) with videos related to

Pageof 20
Sort By:
Statistics in Medicine|July 5, 2022
Unified estimation for Cox regression model with nonmonotone missing at random covariatesDavid Luke Thiessen, Yang Zhao, Dongsheng Tu
The Clinical Journal of Pain|July 4, 2012
Sensory and affective pain descriptors respond differentially to pharmacological interventions in neuropathic conditionsIan Gilron, Dongsheng Tu, Ronald R Holden
The Lancet. Oncology|December 5, 2024
Palliative radiotherapy for hepatic cancer pain - Authors' replyLaura A Dawson, Dongsheng Tu, Christopher J O'Callaghan
Journal of the National Cancer Institute|August 14, 2025
Financial difficulty among patients with cancer participating in clinical trials and its association with patient survival and quality of lifeBishal Gyawali, Nan Chen, Dongsheng Tu, et al.
Statistics in Medicine|June 27, 2012
Variable selection in semiparametric cure models based on penalized likelihood, with application to breast cancer clinical trialsXiang Liu, Yingwei Peng, Dongsheng Tu, et al.
Journal of Biopharmaceutical Statistics|November 16, 2023
A composite semiparametric homogeneity test for the distributions of multigroup interval-bounded longitudinal dataZhanfeng Wang, Wenmei Li, Hao Ding, et al.
Statistics in Medicine|August 20, 2023
A threshold longitudinal Tobit quantile regression model for identification of treatment-sensitive subgroups based on interval-bounded longitudinal measurements and a continuous covariateZhanfeng Wang, Tao Li, Liqun Xiao, et al.
Pharmaceutical Statistics|January 31, 2026
A Tobit Partly Linear Mixed and Mixture Cure Model for the Joint Analysis of Interval-Bounded Longitudinal Measurements and Survival Times With Cure ProportionZhanfeng Wang, Zerui Shen, Ruixing Ming, et al.
BMC Medical Research Methodology|June 23, 2011
A comparison of a new multinomial stopping rule with stopping rules of fleming and gehan in single arm phase II cancer clinical trialsJohn R Goffin, Greg R Pond, Dongsheng Tu
Contemporary Clinical Trials Communications|May 9, 2018
Survival analysis following dynamic randomizationXiaolong Luo, Mingyu Li, Gongjun Xu, et al.
Pageof 20

Showing results (11-20 of 200) with videos related to

Sort By:
Pageof 20
Statistics in Medicine|July 5, 2022
Unified estimation for Cox regression model with nonmonotone missing at random covariatesDavid Luke Thiessen, Yang Zhao, Dongsheng Tu
The Clinical Journal of Pain|July 4, 2012
Sensory and affective pain descriptors respond differentially to pharmacological interventions in neuropathic conditionsIan Gilron, Dongsheng Tu, Ronald R Holden
The Lancet. Oncology|December 5, 2024
Palliative radiotherapy for hepatic cancer pain - Authors' replyLaura A Dawson, Dongsheng Tu, Christopher J O'Callaghan
Journal of the National Cancer Institute|August 14, 2025
Financial difficulty among patients with cancer participating in clinical trials and its association with patient survival and quality of lifeBishal Gyawali, Nan Chen, Dongsheng Tu, et al.
Statistics in Medicine|June 27, 2012
Variable selection in semiparametric cure models based on penalized likelihood, with application to breast cancer clinical trialsXiang Liu, Yingwei Peng, Dongsheng Tu, et al.
Journal of Biopharmaceutical Statistics|November 16, 2023
A composite semiparametric homogeneity test for the distributions of multigroup interval-bounded longitudinal dataZhanfeng Wang, Wenmei Li, Hao Ding, et al.
Statistics in Medicine|August 20, 2023
A threshold longitudinal Tobit quantile regression model for identification of treatment-sensitive subgroups based on interval-bounded longitudinal measurements and a continuous covariateZhanfeng Wang, Tao Li, Liqun Xiao, et al.
Pharmaceutical Statistics|January 31, 2026
A Tobit Partly Linear Mixed and Mixture Cure Model for the Joint Analysis of Interval-Bounded Longitudinal Measurements and Survival Times With Cure ProportionZhanfeng Wang, Zerui Shen, Ruixing Ming, et al.
BMC Medical Research Methodology|June 23, 2011
A comparison of a new multinomial stopping rule with stopping rules of fleming and gehan in single arm phase II cancer clinical trialsJohn R Goffin, Greg R Pond, Dongsheng Tu
Contemporary Clinical Trials Communications|May 9, 2018
Survival analysis following dynamic randomizationXiaolong Luo, Mingyu Li, Gongjun Xu, et al.
Pageof 20